In the CNS, gains and amplifications of these genes have also been reported in gliomas, and it has been evidenced that PLAGL2 promotes renewal of neural stem cells/progenitor cells by inhibiting their differentiation and thus promoting gliomagenesis [31]. This evidence concerns the gene PLAGL2 and central nervous system cancer.